Keywords: تیروفیگان; acute coronary syndromes; tirofiban; alveolar hemorrhage;
مقالات ISI تیروفیگان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تیروفیگان; GP IIb/IIIa inhibitor; Tirofiban; Intracoronary; STEMI;
Keywords: تیروفیگان; Dual antiplatelet therapy; PCI; Periprocedural myocardial infarction; Tirofiban;
Keywords: تیروفیگان; heparin-induced thrombocytopenia; type I; type II; platelet factor 4; enzyme-linked immunosorbent assay; optical density; serotonin-release assay; bivalirudin; argatroban; thrombosis; bleeding; transfusion; heart transplantation; platelet anesthesia; ilop
Keywords: تیروفیگان; Tirofiban; Acute ischemic stroke; Safety; Outcomes; Arterial occlusion; Cerebrovascular disease; Endovascular treatment; Antiplatelet;
Keywords: تیروفیگان; Index of microcirculatory resistance; Tirofiban; Delayed percutaneous coronary intervention
Stentriever Thrombectomy Failure: A Challenge in Stroke Management
Keywords: تیروفیگان; Mechanical thrombectomy; Stent; Stroke; Tirofiban; CT; Computed tomography; CTA; Cerebral tomography angiography; CTp; Perfusion computed tomography; DSA; Digital subtraction angiography; ICA; Internal cerebral artery; ICH; Intracerebral hemorrhage; LAO;
Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial
Keywords: تیروفیگان; buffers; non-ST-segment elevation acute coronary syndrome; thrombocytopenia; tirofiban; ACS; acute coronary syndrome; CI; confidence interval; GPI; glycoprotein IIb/IIIa inhibitor; HR; hazard ratio; MI; myocardial infarction; NACE; net adverse cardiovas
Tirofiban induces vasorelaxation of the coronary artery via an endothelium-dependent NO-cGMP signaling by activating the PI3K/Akt/eNOS pathway
Keywords: تیروفیگان; Tirofiban; Vasorelaxation; Coronary artery; No-reflow; PI3K/Akt/eNOS;
Early invasive strategy in high-risk acute coronary syndrome without ST-segment elevation. The Sisca randomized trial
Keywords: تیروفیگان; Acute coronary syndrome; High risk patients; Long-term outcome; Tirofiban; Prehospital;
Effect of Intracoronary Plus Low-Dose Intravenous Tirofiban in Elderly Patients with Acute Myocardial Infarction
Keywords: تیروفیگان; Acute myocardial infarction; Percutaneous coronary intervention; Tirofiban; Adverse cardiac events; Coronary artery disease
Cardiovascular pharmacologyProtective effects of tirofiban on ischemia/reperfusion-induced renal injury in vivo and in vitro
Keywords: تیروفیگان; Tirofiban; Renal ischemia-reperfusion; Oxidative stress; Apoptosis;
Platelet aggregation inhibition by Eptifibatide versus high dose Tirofiban during primary percutaneous interventions
Keywords: تیروفیگان; Eptifibatide; Tirofiban; GP2b3a; Primary PCI; STEMI
Local intraarterial tirofiban after formation of anterograde flow in patients with acute ischemic stroke: Preliminary experience and short term follow-up results
Keywords: تیروفیگان; Ischemic stroke; Tirofiban; Intraarterial thrombolysis; Mechanical thrombolysis; Glycoprotein IIb/IIIa antagonists
Intra-arterial tirofiban infusion for thromboembolic complication during coil embolization of ruptured intracranial aneurysms
Keywords: تیروفیگان; Aneurysm; Tirofiban; Thromboembolism; Coil embolization;
A fatal complication of tirofiban in an octogenarian: Diffuse alveolar hemorrhage
Keywords: تیروفیگان; Glycoprotein IIb/IIIa antagonist; Tirofiban; Acute coronary syndrome; Diffuse alveolar hemorrhage
Prehospital high-dose tirofiban in patients undergoing primary percutaneous intervention. The AGIR-2 study
Keywords: تیروفیگان; Acute myocardial infarction; Tirofiban; Glycoprotein IIb/IIIa inhibitor; Prehospital care; Primary angioplastyInfarctus du myocarde; Tirofiban; Inhibiteur du glycoprotéine IIb/IIIa; Soins préhospitalier; Angioplastie primaire
Emergency coronary artery bypass grafting in patients with acute myocardial infarction treated with glycoprotein IIb/IIIa receptor inhibitors
Keywords: تیروفیگان; Emergency CABG; Acute myocardial infarction; Abciximab; Eptifibatide; Tirofiban;
Antiplatelet Drugs : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Keywords: تیروفیگان; abciximab; antiplatelet drugs; aspirin; clopidogrel; dipyridamole; eptifibatide; platelet pharmacology; resistance; ticlopidine; tirofiban
Effects of escalating doses of tirofiban on platelet aggregation and major receptor expression in diabetic patients: Hitting the TARGET in the TENACITY trial?
Keywords: تیروفیگان; Tirofiban; Platelets; In vitro; Diabetes; Acute coronary syndrome;
Efectividad y seguridad de la «triple antiagregación» en pacientes sometidos a intervencionismo coronario
Keywords: تیروفیگان; isquemia miocárdica; supervivencia; infarto de miocardio; sÃndrome coronario agudo sin elevación de ST; angina; revascularización percutánea; angioplastia coronaria; clopidogrel; ticlopidina; tienopiridinas; abciximab; tirofiban; eptifibátido; antag
Comparison of abciximab with “high-dose” tirofiban in patients undergoing percutaneous coronary intervention
Keywords: تیروفیگان; Coronary disease; Stenting; Tirofiban; Abciximab; Glycoprotein inhibitor
Chirurgie cardiaque effectuée avec une association héparine non fractionnée et inhibiteur des récepteurs GPIIbIIIa plaquettaire (tirofiban) pour suspicion de TIH
Keywords: تیروفیگان; Thrombopénie induite par l'héparine; Inhibiteur des récepteurs GPIIbIIIa plaquettaires; Tirofiban; Chirurgie cardiaque; Circulation extracorporelleHeparin-induced thrombocytopenia; Platelet GPIIbIIIa antagonist; Tirofiban; Cardiac surgery; Cardiopulmonary
Collagen XVII promotes integrin-mediated squamous cell carcinoma transmigration—A novel role for αIIb integrin and tirofiban
Keywords: تیروفیگان; BP180; Hemidesmosome; Tirofiban; Integrin; Keratinocyte
Analysis of bleeding complications associated with glycoprotein IIb/IIIa receptors blockade in patients with high-risk acute coronary syndromes: Insights from the PRISM-PLUS study
Keywords: تیروفیگان; Thrombocytopenia; Tirofiban; Heparin; Glycoprotein IIb/IIIa inhibitors; Acute coronary syndromes; Bleeding;
Immune Thrombocytopenia Caused by Glycoprotein IIb/IIIa Inhibitors
Keywords: تیروفیگان; abciximab; eptifibatide; glycoprotein IIb/IIIa inhibitors; thrombocytopenia; tirofiban; DITP; drug-induced immune thrombocytopenia; EDTA; ethylendiaminetetraacetic acid; GP; glycoprotein; RGD; Arg-Gly-Asp;
Facilitated percutaneous coronary intervention (PCI) in patients with acute ST-elevation myocardial infarction: Comparison of prehospital tirofiban versus fibrinolysis before direct PCI
Keywords: تیروفیگان; ST-elevation myocardial infarction; Facilitated direct PCI; Tirofiban; Fibrinolysis;
Pharmacodynamics and pharmacokinetics of the platelet GPIIb/IIIa inhibitor tirofiban in patients undergoing percutaneous coronary intervention: implications for adjustment of tirofiban and clopidogrel dosage
Keywords: تیروفیگان; GPIIb/IIIa; platelet glycoprotein (GP) IIb/IIIa; PCI; percutaneous coronary intervention; ACS; acute coronary syndromes; NSTE; non-ST-segment elevation; MI; myocardial infarction; PRP; platelet-rich-plasma; PPP; platelet-poor plasma; Tirofiban; Clopidogre